PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

106 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
61.
Justenhoven, C.* et al.: Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors. Int. J. Cancer 124, 2077-2081 (2009)
62.
Krönig, H.* et al.: Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity. Int. J. Cancer 125, 649-655 (2009)
63.
Steinbrecher, A.* ; Nimptsch, K.* ; Hüsing, A.* ; Rohrmann, S.* & Linseisen, J.: Dietary glucosinolate intake and risk of prostate cancer in the EPIC-Heidelberg cohort study. Int. J. Cancer 125, 2179-2186 (2009)
64.
Lüking, C. et al.: Antitumor effector functions of T cells are dependent on in vivo priming and restricted T-cell receptor expression. Int. J. Cancer 122, 2280-2285 (2008)
65.
Naschberger, E.* et al.: Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy. Int. J. Cancer 123, 2120-2129 (2008)
66.
Smith, J.S.* et al.: Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer. Int. J. Cancer 123, 2469-2471 (2008)
67.
Schlee, M. et al.: c-MYC activation impairs the NF-kappaB and the interferon response: Implications for the pathogenesis of Burkitt's lymphoma. Int. J. Cancer 120, 1387-1395 (2007)
68.
Yoon, H.* et al.: Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest. Int. J. Cancer 121, 767-775 (2007)
69.
Rosemann, M. et al.: Multilocus inheritance determines predisposition to alpha-radiation induced bone tumourigenesis in mice. Int. J. Cancer 118, 2132-2138 (2006)
70.
Beckers, J. et al.: Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis. Int. J. Cancer 114, 590-597 (2005)
71.
Mautner, J. ; Jaffee, E.M.* & Pardoll, D.M.*: Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigens. Int. J. Cancer 115, 752-759 (2005)
72.
Paschen, A.* et al.: Melanoma patients respond to a new HLA-1*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2. Int. J. Cancer 116, 944-948 (2005)
73.
Siedlar, M.* et al.: Depressed tumor necrosis factor alpha and interleukin-12p40 production by peripheral blood mononuclear cells of gastric cancer patients: Association with IL-1R-associated kinase-1 protein expression and disease lung stage. Int. J. Cancer 114, 144-152 (2005)
74.
Brennan, P.* et al.: Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: A pooled analysis of two large studies. Int. J. Cancer 109, 125-131 (2004)
75.
Lotz, C.* et al.: Partial tyrosinase-specific self tolerance by HLA-A*0201-restricted cytotoxic T lymphocytes in mice and man. Int. J. Cancer 108, 571-579 (2004)
76.
Rosivatz, E.* et al.: Neoexpression of N-cadherin in E-cadherin positive colon cancers. Int. J. Cancer 111, 711-719 (2004)
77.
Ruf, P.* et al.: Two new trifunctional antibodies for the therapy of human malignant melanoma. Int. J. Cancer 108, 725-732 (2004)
78.
Siegler, G.* et al.: Expression of tumor necrosis factor receptor-associated factor 1 in nasopharyngeal carcinoma: Possible upregulation by Epstein-Barr virus latent membrane proteine 1. Int. J. Cancer 112, 265-272 (2004)
79.
Walch, A.K.* et al.: Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma. Int. J. Cancer 112, 747-753 (2004)
80.
Behrends, U. et al.: Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. Int. J. Cancer 106, 244-251 (2003)